Domingo Leyba Suspended 80 Games After Positive PED Test
Diamondbacks infielder Domingo Leyba has been suspended for eighty games, per a league announcement. He tested positive for boldenone, a banned performance-enhancing drug.
Leyba, a 24-year-old switch-hitter, made his MLB debut last year. He spent most of the year at Triple-A, where he turned in a strong .300/.351/.519 batting line with 19 home runs. In the highly charged PCL offensive environment, that output was good for a 107 wRC+.
The Snakes had already closed off Leyba’s most direct route to playing time when they added Starling Marte, thus pushing Ketel Marte back to second base. Leyba still factored into the mix as a potential utility infielder, where he faced competition from players such as Ildemaro Vargas, Josh Rojas, Andy Young, and non-roster invitee Gavin Cecchini.
Orioles Return Rule 5 Picks Brandon Bailey, Michael Rucker
3:01pm: The O’s announced that both players have cleared waivers and been returned to their prior teams.
1:37pm: The Orioles have decided against carrying both of their Rule 5 selections from the December draft, GM Mike Elias told media members including Jon Meoli of the Baltimore Sun (via Twitter). The departures of righties Brandon Bailey and Michael Rucker will open two 40-man roster spots.
It isn’t yet entirely clear whether these two hurlers have cleared waivers. Every other team in baseball will have (or has had) a chance to step into the O’s Rule 5 rights. If nobody places a claim, then they’ll be offered back to their prior teams — where they will not lock up a big-league roster spot unless and until they’re added.
The 25-year-old Bailey came over from the Astros organization after a strong 2019 season in which he pitched to a 3.30 ERA over 92 2/3 innings at the Double-A level with 10.0 K/9 and 4.0 BB/9. He had been selected with the second overall pick in the Rule 5 draft. The Orioles could’ve utilized him as a swingman in the majors this year but evidently didn’t see enough upside to merit the effort.
As for Rucker, who’s also 25, he’d be heading back to the Cubs. Last year, he transitioned into a full-time reliever, throwing 79 2/3 upper-minors innings over 36 appearances. Rucker carried a 4.18 ERA with a healthy combination of 10.5 K/9 and 2.8 BB/9 on the season. He also threw five scoreless innings over three appearances in camp, with three strikeouts and a pair of free passes.
MLBPA Has Expanded Grievance Against Pirates
The Major League Baseball Players Association has now expanded its grievance proceeding against the Pittsburgh Pirates, Rob Biertempfel of The Athletic reports (subscription link). The union is in both cases challenging the team’s use of revenue-sharing funds.
As the MLBPA looks for ways to spur teams to spend, it has targeted the ever-stingy Bucs. An initial grievance proceeding included the Pittsburgh organization as well as the A’s, Rays, and Marlins.
It seems the initial action covered spending over the 2017-18 offseason, with the new one relating to the winter of 2018-19. Biertempfel spoke with union chief Tony Clark, who didn’t weigh in on this particular matter but did state that his organization remains concerned with “revenue-sharing recipients who remain in that perpetual rebuilding mode.”
The Pirates, of course, claim not to be rebuilding. Newly hired GM Ben Cherington has spoken instead of a “build.” Parsing the terminology won’t change the substance. After a winter in which the team traded Starling Marte and didn’t add back much salary, the Bucs are presently slated to open the season with approximately $57MM in player salaries on their books. That marks the club’s lowest Opening Day payroll since 2011 and fourth-straight year-over-year decline.
This grievance is obviously only one part of a broader union strategy to push back against some broader trends, but ir remains unclear precisely what remedy the MLBPA can hope to achieve through this mechanism. A team is required to spend revenue-sharing funds “in an effort to improve its performance on the field,” though the collective bargaining agreement contemplates quite a few things beyond MLB salaries as fitting that definition. At the time the first grievance was filed, then-Pirates president Frank Coonelly called it “patently baseless.”
As Biertempfel notes, there’s some interesting potential interaction here between this story and the recent reports of extension possibilities for the Pirates organization. Investing in existing players wouldn’t change the immediate mix of talent, so perhaps it wouldn’t speak directly to the union’s position. But it would go some way towards quelling the understandable angst emanating from the ranks of Pirates fans over the organization’s spending.
Chris Sale Discusses Elbow Outlook
Red Sox lefty Chris Sale has avoided the worst case scenario — for now. That’s the good news. But the situation “sucks,” he acknowledged in a discussion with reporters including Ian Browne of MLB.com (links to Twitter).
Sale has not incurred new damage to the ulnar collateral ligament in his pitching elbow. But he’s still not in the clear. His most recent attempt to ramp up ran into yet more elbow trouble, casting doubt as to whether he can proceed without surgical intervention.
At this point, the veteran southpaw says, he simply doesn’t know what to anticipate. On the one hand, there’s still hope that he’ll be able to return relatively early in the 2020 season. Once the inflammation subsides in a few weeks’ time, he’ll attempt to start throwing again. If everything goes well, Sale might conceivably miss only a month or so of action.
And what if the elbow keeps barking? That would seem to put an end to the rest-and-rehab approach that he and the team have employed since last summer. Sale acknowledged that Tommy John surgery is a possibility. It isn’t entirely clear whether other surgical approaches may also be considered.
It’s a tough spot for the Red Sox, who have $145MM invested in the star southpaw for the next five seasons. Sale offered a tough self-assessment. “I was able to get through most of my career doing what I love to do and helping my team win,” he said. “For sure, over the last year and up to this point, I’ve done nothing but fall flat on my face.”
Those harsh words are surely a reflection of a trying situation. But it’s hard to fault Sale himself for the fix he’s in. He has long been durable, productive, and (by all indications) hard-working. Unfortunately, elbow woes are common for hurlers.
Yankees Scouting Starters, Still Unsure Of Aaron Judge Diagnosis
Injury uncertainty has again struck the Yankees, who’ve gone without a few top starters and bats this spring. While the club isn’t going to panic, it’ll obviously have to make some unexpected decisions to finalize its roster.
GM Brian Cashman said recently that the Yanks haven’t put in calls to inquirer about potential trades to boost a rotation that has lost major pieces for all (Luis Severino) or part (James Paxton) of the coming campaign. That may well be — and it makes sense, given the time of year — but that doesn’t mean the organization is just sitting on its hands.
The Yankees have sent scouts to examine potential starting pitching targets, according to Bob Nightengale of USA Today (Twitter link). Just what level of hurler they’ll be trying to identify isn’t clear. The Yanks could certainly stand to add an established MLB arm, though that’s generally quite difficult to swing just before the start of a season.
More likely, perhaps, the New York org will be looking to acquire some depth. There are quite a few pitchers in camp on minor-league deals. Even those that show reasonably well in the spring may not end up earning 40-man roster spots with their present organization.
It isn’t as if the Yankees’ present options are without merit. As things line up at present, Jordan Montgomery and Jonathan Loaisiga would likely found out the rotation. There’s uncertainty, but both have shown real talent in the past. Veterans Chad Bettis, David Hale, and Nick Tropeano are already in camp for depth.
The Yanks could certainly enter the season with that mix, plus another addition or two, and then plan to adapt as the season goes along. The hope, of course, remains that Paxton will return before too long. And there’s always the summer trade period.
The situation is something of the opposite on the position-player side, where the need isn’t really yet known but the solutions are pretty obvious. Slugger Aaron Judge remains sidelined with a mysterious ailment in his shoulder/chest. There’s still no clarity as to just what the underlying issue is, MLB.com’s Bryan Hoch reports on Twitter.
While it’s impossible to know at present just when Judge will be able to suit up — he says he’s still not ruling himself out for Opening Day, though that seems unlikely — the backup plan isn’t much in doubt. Mike Tauchman, Clint Frazier, and Miguel Andujar are first in line for expanded roles to account for the absences of Judge and Giancarlo Stanton.
Chris Sale Diagnosed With Flexor Strain
March 5: Sale has been diagnosed with a flexor strain, Roenicke tells reporters (Twitter link via Mastrodonato). He’ll be shut down from throwing until next week and even then will be limited to simply playing catch. The next steps will depend on how he responds to that activity. Roenicke notes that Sale’s “UCL looks the same as the last image.”
March 4, 4:35pm: At this point, there’s no expectation that Sale will require Tommy John surgery, Ken Rosenthal of The Athletic tweets.
9:05am: We learned yesterday that star Red Sox lefty Chris Sale had undergone an MRI after he experienced elbow soreness, with Dr. James Andrews set to review the results. That has now occurred, but a diagnosis and course of treatment remain unknown.
Boston manager Ron Roenicke tells reporters, including Jason Mastrodonato of the Boston Herald (Twitter link) and Peter Abraham of the Boston Globe (Twitter link), that the club has sought another opinion. Another premier specialist, Dr. Neal ElAttrache, will review the imaging and weigh in with his opinion.
Presumably, the hope is to land upon a consensus after receiving the viewpoints of Andrews, ElAttrache, and the Sox’ own team medical staff. All involved are taking their time, says Roenicke, because there’s a “need to get this right.”
Sale will ultimately decide upon what course of treatment he deems best. But there’s a shared interest in arriving upon the best long-term approach to his as-yet-unclear elbow ailment. The Red Sox owe Sale $145MM over the next five seasons.
Roenicke says that fans and media shouldn’t read into the ongoing uncertainty. Sale isn’t necessarily staring down Tommy John surgery, it seems. Indeed, it’s not really even clear whether that is a possibility on the table at the moment.
What is known to this point: Sale was shut down and received platelet-rich plasma treatment in August after visiting Andrews. The southpaw said he had been cleared of ligament damage. He was cleared to throw over the winter; indications were that he’d be a full participant in Spring Training. Sale was delayed at the outset of camp, with the explanation given that he was dealing with a case of pneumonia, but began throwing recently without evident issue. But his elbow began barking after facing live hitters recently, prompting this new round of medical analysis.
Rangers View Danny Santana As Primary Center Fielder
Rangers manager Chris Woodward said today that long-time utilityman Danny Santana will see most of the action in center field to open the year, as MLB.com’s TR Sullivan reports on Twitter.
That’s hardly surprising, as the team has long signaled this arrangement after the offseason dust settled. But there was some new uncertainty when the Rangers began running Nick Solak up the middle.
So, does this mean the end of the Solak experiment? Not necessarily. Woodward says the hitter in search of a position has actually looked fairly comfortable since trying out the new spot.
Solak, 25, has limited professional experience on the outfield grass, with most of that coming in the corners. But the Rangers are looking for creative ways to get him into the lineup — quite understandably, given that he has a nice track record of hitting in the minors and posted a .293/.393/.491 slash in his first 135 MLB plate appearances last year.
The switch-hitting Santana was also long a middle infielder before increasingly shifting into outfield duties. He appeared all over the place in a breakout 2019 season, all while slashing a robust .283/.324/.534. Whether he can sustain that outburst remains to be seen. Santana was similarly productive as a rookie back in 2014 but had a long dry spell in the interim.
In the aggregate, it probably doesn’t matter all that much how the Rangers sort things to begin the season. Both Santana and Solak come with some upside and some desirable flexibility. They each also have questions to answer. No doubt the team’s plan is to adapt as the season unfolds.
Pirates To “Explore” Extensions With Young Players
The Pirates expect to “explore multiyear deals” with certain of the team’s early-career MLB players, according to Jon Heyman of MLB Network (via Twitter). The likelihood of agreement isn’t clear.
Recent reporting indicated that teams around the league are pursuing quite a few deals of this kind. It’s not surprising to see the Bucs participating in that effort. Early-career extensions have long been a key part of the team’s strategy. And while the team is in flux from a competitive standpoint, all teams are interested in scenarios that increase the value of their existing control rights over players.
Heyman lists several potential candidates, though it’s not clear which have actually been targeted by the Pittsburgh organization. Outfielder Bryan Reynolds, middle infielder Kevin Newman, and starter Joe Musgrove are all tabbed as possibilities — just the trio you’d likely have thought of.
Reynolds hasn’t even cracked a full year of service, but is coming off of an extremely impressive 2019 debut that might’ve earned him a Rookie of the Year award in some seasons. Newman is still two full seasons away from arbitration. He also put up a strong effort last year, slashing .308/.353/.446 in his first full season in the bigs.
It’s a bit of a different situation for Musgrove, who is already into arbitration eligibility at 27 years of age. He’s slated to earn $2.8MM for the coming season, so he has already locked in significant earnings. Musgrove has been a solid rotation piece since coming over before the 2018 season, compiling 285 2/3 total innings of 4.28 ERA ball.
Griffin Canning To Seek 2nd Opinion On Elbow
Ongoing elbow questions have clouded the outlook of Angels righty Griffin Canning. The team isn’t quite ready to announce a decision on a course of action, as Jeff Fletcher of the Orange County Register reports on Twitter.
Canning was previously said to be slated for testing today. Now, he’s scheduled for a second opinion — though there’s still no public knowledge (quite understandably) regarding the initial examination.
The 23-year-old hurler emerged as a key part of the Halos’ rotation plans last year. But he also ended the season on the injured list owing to elbow troubles and has dealt with other issues in the joint in the past.
The Angels rotation remains a point of focus after a trying 2019 campaign. Even if Canning avoids a significant stay on the injury list, it now seems he’ll join Shohei Ohtani on the injured list to open the 2020 season.
Latest On Jorge Alfaro
The Marlins are still not sure that their top backstop will be ready for the start of the season, but the general prognosis seems promising. Skipper Don Mattingly says that Jorge Alfaro has been cleared to engage in some baseball activities. as MLB.com’s Joe Frisaro was among those to cover on Twitter.
Alfaro has been laying low while dealing with a left oblique strain. While there’s still no indication that it’s a significant injury, it’s always prudent to exercise caution with this particular area of the body. Rather than pushing too hard and risking a more significant injury, the Fish will ease Alfaro back into action.
The Marlins would obviously prefer to have Alfaro behind the dish when the season gets underway. The 26-year-old is a key part of the team’s present and future hopes. After a solid but uneven showing last year, his first in Miami, he’ll be looking to make strides in 2020.
If Alaro is unable to prepare fully for the start of the upcoming campaign, there is a ready-made backup plan in the form of respected veteran Francisco Cervelli. Reserve duties could go to Chad Wallach, the only other backstop on the 40-man. Experienced big leaguer Ryan Lavarnway is also in camp as a non-roster invitee.